A detailed history of Independent Wealth Network Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Independent Wealth Network Inc. holds 2,820 shares of ABBV stock, worth $480,246. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,820
Previous 3,022 6.68%
Holding current value
$480,246
Previous $596,000 15.94%
% of portfolio
0.21%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$164.99 - $203.87 $33,327 - $41,181
-202 Reduced 6.68%
2,820 $501,000
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $128,942 - $156,872
787 Added 35.21%
3,022 $596,000
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $30,958 - $36,152
200 Added 9.83%
2,235 $383,000
Q1 2024

May 20, 2024

BUY
$159.82 - $182.1 $325,233 - $370,573
2,035 New
2,035 $370,000
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $12,246 - $13,792
-89 Reduced 3.83%
2,234 $346,000
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $3,473 - $4,020
-26 Reduced 1.11%
2,323 $346,000
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $75,265 - $93,663
-568 Reduced 19.47%
2,349 $316,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $56,108 - $64,617
388 Added 15.34%
2,917 $464,000
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $5,809 - $6,966
-42 Reduced 1.63%
2,529 $0
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $66,031 - $75,733
492 Added 23.67%
2,571 $345,000
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $31,239 - $39,715
-227 Reduced 9.84%
2,079 $318,000
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $304,345 - $377,607
2,306 New
2,306 $374,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Independent Wealth Network Inc. Portfolio

Follow Independent Wealth Network Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Wealth Network Inc., based on Form 13F filings with the SEC.

News

Stay updated on Independent Wealth Network Inc. with notifications on news.